Menu

GSK headquarters

GSK was one of two drugmakers to issue refunds to 340B covered entities, according to notices posted on a government regulatory site.

News Alert

GSK Loosens 340B Contract Pharmacy Restrictions in Arkansas and Louisiana

October 31, 2023 William Newton Washington Correspondent Views

GlaxoSmithKline (GSK) today became the fifth drug manufacturer to loosen or end its 340B contract pharmacy restrictions in Arkansas and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

William Newton